DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - Q1 2022 holdings

$4.47 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 122 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 27.6% .

 Value Shares↓ Weighting
BuyGLAUKOS CORPnote 2.750% 6/1$358,786,000
+48.0%
269,897,000
+31.9%
8.02%
+57.7%
 NUVALENT INC$268,647,000
-27.0%
19,341,0240.0%6.01%
-22.2%
VTRS SellVIATRIS INC$224,930,000
-20.0%
20,673,700
-0.5%
5.03%
-14.7%
AHCO BuyADAPTHEALTH CORP$186,751,000
-25.3%
11,650,072
+13.9%
4.18%
-20.4%
BuyINVITAE CORPnote 2.000% 9/0$169,769,000
+10.7%
206,873,000
+26.6%
3.80%
+18.0%
NBIX BuyNEUROCRINE BIOSCIENCES INC$155,419,000
+32.4%
1,657,800
+20.3%
3.48%
+41.1%
 AERIE PHARMACEUTICALS INCnote 1.500%10/0$141,877,000
+9.0%
157,390,0000.0%3.17%
+16.2%
 ENVISTA HOLDINGS CORPORATIONnote 2.375% 6/0$123,924,000
+6.3%
52,500,0000.0%2.77%
+13.3%
CMAX SellCAREMAX INC$121,813,000
-5.5%
15,861,090
-5.5%
2.72%
+0.7%
BuyNATERA INCnote 2.250% 5/0$120,177,000
+3.8%
90,638,000
+101.4%
2.69%
+10.7%
NewSAREPTA THERAPEUTICS INCdbcv 1.500%11/1$116,124,00088,657,000
+100.0%
2.60%
 PACIRA BIOSCIENCES INCnote 0.750% 8/0$100,908,000
+11.5%
81,600,0000.0%2.26%
+18.9%
 NUVASIVE INCnote 1.000% 6/0$96,433,000
-0.2%
96,966,0000.0%2.16%
+6.4%
LUNG BuyPULMONX CORP$91,681,000
+20.8%
3,695,341
+56.1%
2.05%
+28.8%
SILK BuySILK RD MED INC$88,927,000
+37.6%
2,153,712
+42.0%
1.99%
+46.6%
ISEE BuyIVERIC BIO INC$82,332,000
+3.4%
4,891,996
+2.7%
1.84%
+10.2%
BuyAPELLIS PHARMACEUTICALS INCnote 3.500% 9/1$81,724,000
+87.7%
51,885,000
+80.0%
1.83%
+100.1%
BuyTABULA RASA HEALTHCARE INCnote 1.750% 2/1$79,740,000
-0.9%
107,816,000
+10.2%
1.78%
+5.6%
 INSULET CORPnote 0.375% 9/0$76,232,000
-0.2%
57,581,0000.0%1.70%
+6.4%
BuyNUVASIVE INCnote 0.375% 3/1$76,133,000
+1.9%
80,000,000
+2.7%
1.70%
+8.6%
BuyINSMED INCnote 1.750% 1/1$74,929,000
+46.0%
75,000,000
+50.0%
1.68%
+55.7%
MIRM  MIRUM PHARMACEUTICALS INC$72,290,000
+38.1%
3,282,9120.0%1.62%
+47.2%
KURA BuyKURA ONCOLOGY INC$71,015,000
+44.4%
4,416,361
+25.7%
1.59%
+53.9%
 NEVRO CORPnote 2.750% 4/0$65,368,000
-4.1%
61,000,0000.0%1.46%
+2.2%
ORGO  ORGANOGENESIS HLDGS INC$64,441,000
-17.5%
8,456,8760.0%1.44%
-12.1%
 INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0$52,992,000
-2.6%
57,791,0000.0%1.18%
+3.9%
DCPH  DECIPHERA PHARMACEUTICALS IN$51,731,000
-5.1%
5,580,4560.0%1.16%
+1.1%
HZNP NewHORIZON THERAPEUTICS PUB L$48,923,000465,000
+100.0%
1.09%
 BRIDGEBIO PHARMA INCnote 2.500% 3/1$47,402,000
-19.5%
80,000,0000.0%1.06%
-14.2%
CNC SellCENTENE CORP DEL$46,624,000
-43.6%
553,800
-44.8%
1.04%
-39.9%
GILD NewGILEAD SCIENCES INC$45,508,000765,489
+100.0%
1.02%
MOH  MOLINA HEALTHCARE INC$45,031,000
+4.9%
134,9890.0%1.01%
+11.8%
AERI  AERIE PHARMACEUTICALS INC$42,725,000
+29.6%
4,695,0200.0%0.96%
+38.2%
SellSEMA4 HOLDINGS CORP$42,515,000
-31.7%
13,848,488
-0.8%
0.95%
-27.3%
OMIC SellSINGULAR GENOMICS SYSTEMS IN$41,722,000
-60.4%
6,612,019
-27.4%
0.93%
-57.8%
ATEC  ALPHATEC HLDGS INC$41,341,000
+0.6%
3,594,8290.0%0.92%
+7.2%
EWTX  EDGEWISE THERAPEUTICS INC$38,151,000
-36.5%
3,933,1370.0%0.85%
-32.4%
BKD BuyBROOKDALE SR LIVING INC$37,922,000
+71.9%
5,379,000
+25.8%
0.85%
+83.2%
CYTK BuyCYTOKINETICS INC$35,069,000
-4.9%
952,703
+17.8%
0.78%
+1.4%
New1LIFE HEALTHCARE INCnote 3.000% 6/1$34,716,00040,000,000
+100.0%
0.78%
 THE ONCOLOGY INSTITUTE INC$32,137,0000.0%3,296,1070.0%0.72%
+6.5%
PHVS SellPHARVARIS N V$28,600,000
+25.7%
1,577,078
-0.3%
0.64%
+34.0%
 NOVAVAX INCnote 3.750% 2/0$26,777,000
-22.2%
25,000,0000.0%0.60%
-17.0%
BLU BuyBELLUS HEALTH INC NEW$25,269,000
+28.2%
3,672,808
+50.0%
0.56%
+36.5%
LRMR  LARIMAR THERAPEUTICS INC$23,613,000
-62.5%
5,830,2490.0%0.53%
-60.0%
RVMD  REVOLUTION MEDICINES INC$22,744,000
+1.4%
891,5870.0%0.51%
+7.9%
MRTX BuyMIRATI THERAPEUTICS INC$22,199,000
+72.0%
270,000
+206.8%
0.50%
+83.0%
GKOS SellGLAUKOS CORP$21,365,000
-58.6%
369,514
-68.2%
0.48%
-55.9%
 XERIS BIOPHARMA HOLDINGS INCnote 5.000% 7/1$21,095,000
-2.2%
18,000,0000.0%0.47%
+4.2%
DAWN SellDAY ONE BIOPHARMACEUTICALS I$20,698,000
-44.2%
2,086,449
-5.3%
0.46%
-40.5%
GDRX NewGOODRX HLDGS INC$18,926,000979,106
+100.0%
0.42%
NUVB  NUVATION BIO INC$18,816,000
-38.1%
3,577,2330.0%0.42%
-34.0%
OM  OUTSET MED INC$18,188,000
-1.5%
400,6220.0%0.41%
+5.2%
 HEALTH CATALYST INCnote 2.500% 4/1$17,171,000
-21.2%
15,000,0000.0%0.38%
-16.0%
IMGN NewIMMUNOGEN INC$16,520,0003,470,675
+100.0%
0.37%
BCRX SellBIOCRYST PHARMACEUTICALS INC$16,455,000
-29.5%
1,012,000
-40.0%
0.37%
-24.9%
 DA32 LIFE SCNCE TEC ACQSTN C$15,544,000
-1.0%
1,600,0000.0%0.35%
+5.8%
PROF  PROFOUND MED CORP$15,424,000
-19.9%
1,713,7970.0%0.34%
-14.6%
 PTC THERAPEUTICS INCnote 3.000% 8/1$15,076,000
-1.6%
14,527,0000.0%0.34%
+5.0%
ALEC  ALECTOR INC$15,036,000
-31.0%
1,055,1920.0%0.34%
-26.5%
SellXILIO THERAPEUTICS INC$14,696,000
-56.4%
2,078,692
-3.5%
0.33%
-53.5%
NewOAK STR HEALTH INCnote 3/1$14,316,00018,000,000
+100.0%
0.32%
SWTX SellSPRINGWORKS THERAPEUTICS INC$14,109,000
-49.6%
249,988
-44.7%
0.32%
-46.4%
EOLS NewEVOLUS INC$13,792,0001,229,234
+100.0%
0.31%
KALV SellKALVISTA PHARMACEUTICALS INC$12,241,000
-21.3%
830,472
-29.3%
0.27%
-16.0%
COGT  COGENT BIOSCIENCES INC$11,991,000
-12.7%
1,601,0000.0%0.27%
-6.9%
MRUS  MERUS N V$11,554,000
-16.9%
437,0000.0%0.26%
-11.3%
KNTE  KINNATE BIOPHARMA INC$11,097,000
-36.5%
985,5680.0%0.25%
-32.2%
APEN  APOLLO ENDOSURGERY INC$10,588,000
-28.2%
1,750,0000.0%0.24%
-23.3%
SRSA  SARISSA CAPITAL ACQUISITN COcl a$9,900,000
+1.1%
999,9990.0%0.22%
+7.8%
EUCR  EUCRATES BIOMEDICAL ACQU COR$9,840,000
+0.8%
999,9990.0%0.22%
+7.3%
SNRH  SENIOR CONNECT ACQUISITN COR$9,820,000
+0.8%
1,000,0000.0%0.22%
+7.8%
REVH  REVOLUTION HEALTHCAR AQ CORP$9,810,000
+0.7%
1,000,0000.0%0.22%
+7.4%
MTAC  MEDTECH ACQUISITION CORP$9,800,000
-0.8%
999,9990.0%0.22%
+5.8%
INZY  INOZYME PHARMA INC$9,590,000
-40.0%
2,344,7860.0%0.21%
-36.1%
NewAN2 THERAPEUTICS INC$8,803,000584,136
+100.0%
0.20%
 NYXOAH S A$8,714,000
-16.8%
455,2620.0%0.20%
-11.4%
TMPM  TURMERIC ACQUISITION CORPcl a$7,388,000
+0.3%
750,0000.0%0.16%
+7.1%
INSM NewINSMED INC$7,157,000304,572
+100.0%
0.16%
IGNY  IGNYTE ACQUISITION CORP$7,134,000
+1.0%
725,0000.0%0.16%
+7.4%
TERN  TERNS PHARMACEUTICALS INC$6,967,000
-58.0%
2,345,9590.0%0.16%
-55.2%
QSI  QUANTUM SI INC$6,552,000
-40.5%
1,400,0000.0%0.15%
-36.8%
GRAY  GRAYBUG VISION INC$6,497,000
-32.8%
5,281,7130.0%0.14%
-28.6%
 BENEFITFOCUS INCnote 1.250%12/1$6,311,000
+1.3%
6,500,0000.0%0.14%
+7.6%
ONCR  ONCORUS INC$5,605,000
-66.2%
3,148,9770.0%0.12%
-64.1%
VINC  VINCERX PHARMA INC$5,517,000
-60.7%
1,379,3100.0%0.12%
-58.3%
ORTX  ORCHARD THERAPEUTICS PLCads$4,948,000
-46.1%
6,949,4160.0%0.11%
-42.2%
OHPA  ORION ACQUISITION CORP$4,885,000
-0.1%
500,0000.0%0.11%
+5.8%
HOWL  WEREWOLF THERAPEUTICS INC$4,216,000
-63.1%
958,1250.0%0.09%
-60.7%
CGEM SellCULLINAN ONCOLOGY INC$3,932,000
-62.1%
375,585
-44.1%
0.09%
-59.4%
AFIB  ACUTUS MED INC$3,681,000
-59.2%
2,648,3860.0%0.08%
-56.6%
FHTX NewFOGHORN THERAPEUTICS INC$3,638,000238,865
+100.0%
0.08%
RYTM SellRHYTHM PHARMACEUTICALS INC$3,352,000
-82.0%
291,005
-84.4%
0.08%
-80.8%
DCTH  DELCATH SYS INC$3,200,000
-17.4%
500,0000.0%0.07%
-11.1%
GKOS  GLAUKOS CORPcall$2,613,000
+30.1%
45,2000.0%0.06%
+38.1%
AMWL SellAMERICAN WELL CORPcl a$1,647,000
-72.5%
391,115
-60.5%
0.04%
-70.6%
 NEOGENOMICS INCnote 0.250% 1/1$1,666,000
-21.9%
2,500,0000.0%0.04%
-17.8%
ANNX  ANNEXON INC$1,594,000
-76.2%
583,9130.0%0.04%
-74.5%
 THE ONCOLOGY INSTITUTE INC*w exp 11/15/202$1,438,000
+66.6%
1,250,0000.0%0.03%
+77.8%
BCAB  BIOATLA INC$1,445,000
-74.5%
289,0020.0%0.03%
-73.1%
CMAXW  CAREMAX INC*w exp 06/08/202$1,277,000
+35.7%
672,0000.0%0.03%
+45.0%
MDVL  MEDAVAIL HOLDINGS INC$1,110,000
-30.6%
1,142,5520.0%0.02%
-26.5%
CABA  CABALETTA BIO INC$942,000
-46.5%
464,2520.0%0.02%
-43.2%
 ROIVANT SCIENCES LTD*w exp 09/30/202$880,000
-57.0%
1,000,0000.0%0.02%
-53.5%
BFLYWS  BUTTERFLY NETWORK INC*w exp 02/12/202$748,000
-19.7%
733,3330.0%0.02%
-15.0%
QSIAW  QUANTUM SI INC*w exp 06/10/202$383,000
-36.2%
333,3330.0%0.01%
-30.8%
 SOMALOGIC INC*w exp 08/31/202$257,000
-35.9%
120,0000.0%0.01%
-25.0%
SRSAW NewSARISSA CAPITAL ACQUISITN CO*w exp 10/23/202$120,000333,333
+100.0%
0.00%
NUVBWS  NUVATION BIO INC*w exp 07/07/202$135,000
-57.1%
166,6660.0%0.00%
-57.1%
IGNYW  IGNYTE ACQUISITION CORP*w exp 01/05/202$132,000
-52.7%
362,5000.0%0.00%
-50.0%
TMPMW  TURMERIC ACQUISITION CORP*w exp 10/08/202$82,000
-51.8%
250,0000.0%0.00%
-50.0%
REVHW  REVOLUTION HEALTHCAR AQ CORP*w exp 12/31/202$90,000
-40.0%
200,0000.0%0.00%
-33.3%
MTACW  MEDTECH ACQUISITION CORP*w exp 12/22/202$85,000
-51.1%
333,3330.0%0.00%
-50.0%
SNRHW  SENIOR CONNECT ACQUISITN COR*w exp 12/31/202$90,000
-65.8%
500,0000.0%0.00%
-66.7%
OHPAW  ORION ACQUISITION CORP*w exp 02/19/202$39,000
-51.9%
125,0000.0%0.00%
-50.0%
EUCRW  EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202$62,000
-67.9%
333,3330.0%0.00%
-75.0%
 SURROZEN INC*w exp 08/01/203$42,000
-78.1%
166,6660.0%0.00%
-75.0%
WINT  WINDTREE THERAPEUTICS INC$23,000
-28.1%
20,1480.0%0.00%0.0%
SRSAU NewSARISSA CAPITAL ACQUISITN COunit 10/23/2027$01
+100.0%
0.00%
MTACU NewMEDTECH ACQUISITION CORPunit 12/18/2025$01
+100.0%
0.00%
PMVP SellPMV PHARMACEUTICALS INC$10,000
-99.9%
470
-99.9%
0.00%
-100.0%
EUCRU NewEUCRATES BIOMEDICAL ACQU CORunit 10/23/2027$01
+100.0%
0.00%
BDSI ExitBIODELIVERY SCIENCES INTL IN$0-29,204
-100.0%
-0.00%
WVE ExitWAVE LIFE SCIENCES LTD$0-552,690
-100.0%
-0.04%
ExitPYXIS ONCOLOGY INC$0-311,754
-100.0%
-0.07%
ExitDEFINITIVE HEALTHCARE CORP$0-250,000
-100.0%
-0.14%
ExitHYPERFINE INC$0-1,000,000
-100.0%
-0.15%
PRVA ExitPRIVIA HEALTH GROUP INC$0-300,000
-100.0%
-0.16%
ExitGUARDANT HEALTH INCnote 11/1$0-8,000,000
-100.0%
-0.17%
ExitWEAVE COMMUNICATIONS INC$0-554,519
-100.0%
-0.18%
ExitLIANBIOsponsored ads$0-1,782,747
-100.0%
-0.23%
BPMC ExitBLUEPRINT MEDICINES CORP$0-110,000
-100.0%
-0.25%
SRPT ExitSAREPTA THERAPEUTICS INC$0-141,000
-100.0%
-0.27%
APLS ExitAPELLIS PHARMACEUTICALS INC$0-343,213
-100.0%
-0.34%
BBIO ExitBRIDGEBIO PHARMA INCcall$0-1,000,000
-100.0%
-0.35%
NVRO ExitNEVRO CORP$0-216,000
-100.0%
-0.37%
FIGS ExitFIGS INCcl a$0-829,707
-100.0%
-0.48%
VIVO ExitMERIDIAN BIOSCIENCE INC$0-1,125,083
-100.0%
-0.48%
ESPR ExitESPERION THERAPEUTICS INC NE$0-5,000,000
-100.0%
-0.52%
PCRX ExitPACIRA BIOSCIENCES INC$0-596,338
-100.0%
-0.75%
PTGX ExitPROTAGONIST THERAPEUTICS INC$0-1,172,943
-100.0%
-0.84%
APR ExitAPRIA INC$0-1,655,795
-100.0%
-1.13%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AERIE PHARMACEUTICALS INC36Q3 20223.6%
CENTENE CORP DEL30Q3 20233.0%
BIOCRYST PHARMACEUTICALS INC29Q3 20232.2%
MOLINA HEALTHCARE INC26Q3 20221.7%
EHEALTH INC25Q3 20202.0%
INTERCEPT PHARMACEUTICALS IN24Q1 20232.2%
MYLAN NV23Q3 20206.2%
PORTOLA PHARMACEUTICALS INC23Q1 20196.0%
BROOKDALE SR LIVING INC23Q3 20232.2%
ALIMERA SCIENCES INC23Q3 20190.8%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.

Latest significant ownerships (13-D/G)
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
DA32 Life Science Tech Acquisition Corp.August 01, 20235,145,00091.1%
CareMax, Inc.March 13, 202318,691,42316.4%
CareMax, Inc.June 02, 202218,691,42320.7%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.

Latest filings
TypeFiled
32024-03-19
42024-03-19
42024-03-12
32024-03-08
42024-02-16
13F-HR2024-02-14
42024-02-08
32024-02-01
42023-11-21
13F-HR2023-11-14

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.

Compare quarters

Export DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s holdings